OSHA Head To Speak At Occupational Safety And Health Research Symposium
UC's fifth annual symposium featuring research trainees and young investigators in occupational safety and health will be held Oct. 2122 in Kehoe Auditorium.
The guest speaker will be John L. Henshaw, head of the Occupational Safety and Health Administration (OSHA).
The symposium features grant recipients in the Occupational Health and Safety Pilot Research Project, established by UC to support research trainees and young investigators and to encourage those in related disciplines to pursue research in this field.
Grants are provided through UCs Occupational Health and Safety Education and Research Center, one of 16 such centers funded by the National Institute for Occupational Safety and Health (NIOSH).
One hour of American Board of Industrial Hygiene (ABIH) credit has been applied for and may be given to symposium attendees.
Kehoe Auditorium is in the Kettering Laboratory Building on the UC Medical Center campus. The symposium will be free and open to the public. For more information or to register, call Diane Bolden at 513-558-1747.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.